Gi-Dependent Cell Signaling Responses of the Human P2Y14 Receptor in Model Cell Systems
- 1 July 2009
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 330 (1) , 162-168
- https://doi.org/10.1124/jpet.109.150730
Abstract
Eight G protein-coupled receptors comprise the P2Y receptor family of cell signaling proteins. The goal of the current study was to define native cell signaling pathways regulated by the uridine nucleotide sugar-activated P2Y14 receptor (P2Y14-R). The P2Y14-R was stably expressed in human embryonic kidney (HEK) 293 and C6 rat glioma cells by retroviral infection. Nucleotide sugar-dependent P2Y14-R activation was examined by measuring inhibition of forskolin-stimulated cAMP accumulation. The effect of P2Y14-R activation on mitogen-activated protein kinase signaling also was studied in P2Y14-HEK293 cells and in differentiated HL-60 human myeloid leukemia cells. UDP-Glc, UDP-galactose, UDP-glucuronic acid, and UDP-N-acetylglucosamine promoted inhibition of forskolin-stimulated cAMP accumulation in P2Y14-HEK293 and P2Y14-C6 cells, and this signaling effect was abolished by pretreatment of cells with pertussis toxin. Inhibition of cAMP formation by nucleotide sugars also was observed in direct assays of adenylyl cyclase activity in membranes prepared from P2Y14-C6 cells. UDP-Glc promoted concentration-dependent and pertussis toxin-sensitive extracellular signal-regulated kinase (ERK) 1/2 phosphorylation in P2Y14-HEK293 cells. P2Y14-R mRNA was not observed in wild-type HL-60 cells but was readily detected in dimethyl sulfoxide-differentiated cells. Consistent with this observation, no effect of UDP-Glc was observed in wild-type HL-60 cells, but UDP-Glc-promoted pertussis toxin-sensitive activation of ERK1/2 occurred after differentiation. These results illustrate that the human P2Y14-R signals through Gi to inhibit adenylyl cyclase, and P2Y14-R activation also leads to ERK1/2 activation. This work also identifies two stable P2Y14-R-expressing cell lines and differentiated HL-60 cells as model systems for the study of P2Y14-R-dependent signal transduction.Keywords
This publication has 42 references indexed in Scilit:
- Similarities between UDP-Glucose and Adenine Nucleotide Release in Yeast: Involvement of the Secretory PathwayBiochemistry, 2008
- UDP Is a Competitive Antagonist at the Human P2Y14 ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Thrombin‐promoted release of UDP‐glucose from human astrocytoma cellsBritish Journal of Pharmacology, 2008
- Coordinated release of nucleotides and mucin from human airway epithelial Calu‐3 cellsThe Journal of Physiology, 2007
- Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory painJournal of Clinical Investigation, 2007
- A Chemoattractant-mediated Gi-coupled Pathway Activates Adenylyl Cyclase in Human NeutrophilsMolecular Biology of the Cell, 2007
- Polarized expression of human P2Y receptors in epithelial cells from kidney, lung, and colonAmerican Journal of Physiology-Cell Physiology, 2005
- P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrowhematopoietic stem cellsGenes & Development, 2003
- Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase CBritish Journal of Pharmacology, 1997
- G-Protein-coupled receptors in HL-60 human leukemia cellsGeneral Pharmacology: The Vascular System, 1996